NCT02330133|CompletedPhase 2
Mid-life Women: Preventing Unintended Pregnancy and STIs
FemRepro_2
Loading search results
FemRepro_2
Sponsor study identifier
Secondary identifiers
NIH
interventional
333
1 country
1
Study Start
May 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2009
Actual (reported)Study Completion
September 2009
Actual (reported)Mid-life women, aged 35-50, are currently an underserved population in the areas of unintended pregnancy and STI prevention interventions. Common perception is that women in this age range are no longer sexually active, or are past the menopause transition, but in reality, sexual activity remains stable through mid-life and into the post-menopausal years. Additionally, physiological and relationship status changes (e.g. divorce or death of a partner) put these women at increased risk for both unintended pregnancy and STI's. This project developed and evaluated a theoretically-based multimedia intervention designed to assist mid-life women in protecting themselves from sexually transmitted infections and unintended pregnancy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2008
Date type not reportedThis date has not been verified as actual or estimated.
September 2009
Actual (reported)September 2009
Actual (reported)May 4, 2010
Actual (reported)January 1, 2015
Actual (reported)Knowledge of reproductive health issues
A 22-item knowledge scale was created to assess content areas of the program (e.g., 3 items on anatomy \& physiology, 16 items on pregnancy prevention, and 4 items on STI prevention). For example, users were asked to answer the question "A women is most likely to become pregnant (no matter how long or short her menstrual cycle) if she has sexual intercourse about:" with choices being (a) 1 week before menstruation beings, (b) 2 weeks after menstruation begins, (c) 2 weeks before menstruation begins, (d) 1 week after menstruation begins, or (e) do not know.
7-day posttest and 30-day follow-up
Attitudes about reproductive health and prevention
7-day posttest and 30-day follow-up
Self-efficacy for engaging in strategies to prevent pregnancy and communicate with partner about health risks
7-day posttest and 30-day follow-up
Intentions to engage in strategies to prevent pregnancy and communicate with
7-day posttest and 30-day follow-up
Targeted text and video information on website for women aged 25-55 to avoid unplanned pregnancy and sexually transmitted infections
Online general text-based information about reproductive health issues and STD prevention strategies
Targeted text and video information on website for women aged 25-55 to avoid unplanned pregnancy and sexually transmitted infections
Online general text-based information about reproductive health issues and strategies for preventing sexually transmitted infections
Oregon Center for Applied Science
Eugene, Oregon, 97401, United States
Lynne H Grilley Swartz, MPH, CHES
Oregon Center for Applied Science
333 participants (actual enrollment reported by the registry).
First Submitted
May 4, 2010
First Posted
January 1, 2015
Study Start
May 2008
Date type not reportedThis date has not been verified as actual or estimated.
A Trial to Determine People's Explicit vs. Implicit Preferences for Gender-inclusive Sexual and Reproductive Health Content
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
September 2009
Actual (reported)Study Completion
September 2009
Actual (reported)Last Updated
January 1, 2015
Record last verified: 2014-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: